{
  "id": "biomarker-compliance",
  "type": "biomarker_analysis",
  "display_name": "Biomarker Testing Compliance",
  "description": "Analysis of biomarker testing compliance across cancer types",
  "patient_count": 3850,
  "summary": "Overall biomarker testing compliance is at 72%, with significant variation by cancer type and practice location.",
  "created_date": "2023-04-22",
  "charts": [
    {
      "title": "Biomarker Testing Compliance by Cancer Type",
      "chart_type": "bar",
      "data_source": "biomarker-compliance-details.json"
    }
  ],
  "recommendations": [
    "Implement universal reflex biomarker testing protocols",
    "Establish quality metrics for biomarker turnaround time",
    "Develop provider education program on biomarker-guided therapy selection"
  ]
} 